Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |